Klarquist Sparkman, LLP
Klarquist Sparkman, LLP is an intellectual property law firm specializing in patent, trademark, and copyright services for federal agencies. Registered in the System for Award Management (SAM) since 2004, the firm is a for-profit organization that provides comprehensive legal support to government agencies, with a primary focus on patent legal services. The firm's expertise centers on intellectual property protection, particularly in scientific and medical research domains, offering services such as filing patent applications, responding to patent office actions, and managing patent portfolios for federally funded research programs.
The firm has been awarded numerous federal contract delivery orders primarily from agencies within the Department of Health and Human Services, including the National Institutes of Health (NIH), Food and Drug Administration (FDA), and Centers for Disease Control and Prevention (CDC). These contracts consistently involve patent legal services across various scientific disciplines, including biotechnology, chemistry, medical engineering, and software. The delivery orders, typically ranging from $10,000 to $4,610,662, cover tasks such as drafting and filing provisional and non-provisional patent applications, responding to patent office actions, performing conflict of interest checks, and pursuing international patent protection. Notably, all of Klarquist Sparkman's federal contract awards have been made without set-aside designations, indicating the firm competes for contracts based on its specialized expertise.
Klarquist Sparkman holds two significant indefinite-delivery/indefinite-quantity (IDIQ) contracts: a $115 million multiple-award NIH Patent Legal Services contract and a $5 million single-award FDA patent legal support contract. The NIH contract, awarded in April 2020, covers patent legal services across biotechnology, chemistry, medical engineering, and software for various NIH institutes and the CDC. The FDA contract, awarded in August 2022, provides comprehensive patent legal support through July 2027. Under these IDIQ vehicles, the firm has received numerous delivery orders from agencies like the National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Heart, Lung and Blood Institute, and the FDA's Office of the Commissioner. These contracts demonstrate the federal government's reliance on Klarquist Sparkman's specialized intellectual property expertise to support critical health, research, and technological innovation initiatives.
C75KZNSK3CL4 541110
Not listed 121 SW Salmon St #1600, Portland, OR 97204, USA
6/4/04 8/8/25 Burns & Levinson LLP
Burns & Levinson LLP is a law firm registered to receive federal contract awards from the U.S. government. The firm specializes in providing patent legal services to various federal agencies, particularly within the National Institutes of Health (NIH) and its associated institutes. Burns & Levinson LLP has been registered in SAM.gov since June 21, 2019, with its current registration set to expire on April 16, 2025. As a partnership or limited liability partnership, the firm is classified as a for-profit organization in the federal contracting system.
The firm has been awarded several delivery orders under the NIH Patent Legal Services indefinite-delivery/indefinite-quantity (IDIQ) contract. These awards primarily involve drafting and filing patent applications, including Patent Cooperation Treaty (PCT) applications and provisional applications, for technologies developed by NIH scientists. Specific examples include a $13,844.50 award from the National Institute of Environmental Health Sciences (NIEHS) for filing a PCT application related to disclosure E-184-2024-0, and a $12,498 award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for conflict of interest checks and drafting a provisional application. Another award of $10,665 came from the National Heart, Lung and Blood Institute for a PCT application related to an imaging invention. These contracts demonstrate Burns & Levinson LLP's expertise in handling intellectual property matters across various scientific and technological fields for federal health research agencies.
Burns & Levinson LLP holds a position on the NIH Patent Legal Services multiple-award IDIQ contract, which has a total ceiling value of $520 million over ten years. This IDIQ, awarded by the NIH Office of Logistics and Acquisition Operations, covers four technology categories: biotechnology, chemistry, mechanical engineering, and software. Under this vehicle, Burns & Levinson LLP can receive task orders for services such as patent prosecution, intellectual property protection, and related legal activities to support NIH's technology transfer centers and the Centers for Disease Control and Prevention. The firm's specific IDIQ award (ID: 75N98020D00064) has a ceiling value of $17 million and runs through April 19, 2025. This contract enables NIH and its associated agencies to efficiently procure specialized legal services for protecting and managing their intellectual property assets across various scientific and technological fields.
VQLVYTM2RBD7 541110
Not listed 125 High St #4, Boston, MA 02110, USA
6/21/19 4/16/25 Mcbee Moore & Vanik IP, LLC
Mcbee Moore & Vanik IP, LLC is a boutique intellectual property law firm specializing in patent legal services for federal agencies, with a primary focus on supporting research and innovation across various scientific disciplines. The firm is registered in the System for Award Management (SAM) and provides comprehensive intellectual property support to multiple institutes within the National Institutes of Health (NIH) and other government agencies. As a for-profit limited liability company, Mcbee Moore & Vanik IP, LLC offers specialized legal services that help protect and manage intellectual property rights for federally funded research, with expertise spanning biotechnology, chemistry, pharmaceuticals, mechanical engineering, and software technologies.
The firm has consistently provided patent-related legal services through numerous federal contract awards, primarily focusing on preparing and filing domestic and international patent applications, conducting prior art searches, developing patent prosecution strategies, and providing patent counseling. Mcbee Moore & Vanik IP, LLC has worked extensively with various NIH institutes, including the National Cancer Institute, National Heart, Lung and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute on Deafness and Other Communication Disorders, and the National Center for Advancing Translational Sciences. Their contract work has involved tasks such as filing national stage patent applications in multiple countries (including Japan, China, and Europe), responding to patent office actions, drafting provisional patent applications, and performing conflict of interest checks. Notably, all of their contract awards have been issued through full and open competition, with no specific small business or set-aside designations.
Mcbee Moore & Vanik IP, LLC holds two significant indefinite-delivery/indefinite-quantity (IDIQ) contracts with the NIH: a $386 million contract for biotechnology patent legal services and a $115 million contract for chemistry-related patent services. These master IDIQ contracts, both awarded on April 20, 2020, with a performance period through April 19, 2025, allow the firm to provide patent prosecution and intellectual property support across four technology categories. The contracts enable various NIH institutes and the Centers for Disease Control and Prevention to issue firm-fixed price or time-and-materials task orders as needed to protect intellectual property rights for inventions arising from federally funded research programs. Through these contracts, Mcbee Moore & Vanik IP, LLC has been instrumental in supporting the NIH's mission of translating scientific discoveries into potential medical advancements by ensuring robust intellectual property protection for groundbreaking research.
EK2YK1DQG131 541110
Not listed 10 S Market St Fl 2, Frederick, MD 21701, USA
8/30/17 10/16/25 Mintz, Levin, Cohn, Ferris, Glovsky And Popeo, P.C.
Mintz, Levin, Cohn, Ferris, Glovsky And Popeo, P.C., doing business as Mintz Levin Cohn, is a corporate entity registered to receive federal contract awards since 2001. The firm primarily provides legal services to the U.S. government, with a focus on patent law and intellectual property matters. Mintz Levin Cohn specializes in supporting federal agencies in areas such as biotechnology, chemistry, mechanical engineering, and software patent prosecution. The company's expertise in patent legal services aligns with its broader practice as a full-service law firm, likely offering a range of legal counsel to both public and private sector clients.
Mintz Levin Cohn has been awarded several federal contracts, predominantly from agencies within the Department of Health and Human Services. The National Institutes of Health, including its various institutes such as the National Cancer Institute, National Heart Lung and Blood Institute, and National Institute of Allergy and Infectious Diseases, have engaged the firm for patent legal services. These services include drafting and filing patent applications, providing intellectual property advice, and supporting technology transfer activities. The firm has also received a contract from the Department of Energy's Office of Loan Programs for outside counsel work. The awards range from relatively small task orders of around $11,000 to larger contracts exceeding $400,000. Work is typically performed in Boston, Massachusetts, and no set-aside designations were used for these awards. Additionally, Mintz Levin Cohn has acted as a subcontractor to Global Enterprise Solutions, Inc., though the nature of this work is not specified.
The firm holds two significant Indefinite Delivery Contracts (IDVs) under the NIH Patent Legal Services vehicle. The first, valued at $386 million, covers biotechnology patent legal services, while the second, valued at $17 million, is for chemistry-related patent legal services. Both IDVs were awarded in April 2020 with a completion date in April 2023. These multiple-award contracts enable various NIH institutes to issue task orders for specific patent prosecution and intellectual property support needs. The IDVs support the NIH's substantial patent portfolio, allowing the agency to manage approximately 2,500 active patent cases and file 200-300 new applications annually. Through these vehicles, Mintz Levin Cohn provides critical support to the NIH's research and development efforts across a wide range of biomedical fields, facilitating the protection and commercialization of government-funded innovations.
NL1ZA3DRFD98 541110
Not listed One Financial Center, Boston, MA 02110, USA
10/11/01 7/22/25 Mccoy Russell LLP
Mccoy Russell LLP is a Portland, Oregon-based intellectual property law firm specializing in patent legal services for federal agencies. Registered in SAM.gov since May 31, 2017, the firm is a woman-owned small business and self-certified small disadvantaged business that provides comprehensive patent-related legal services to government research and development organizations. The firm primarily offers patent preparation, prosecution, filing, and intellectual property protection services across multiple technological domains, with a focus on supporting federal research institutions' technology transfer objectives.
The firm has consistently been awarded federal contracts through two primary agencies: the National Institutes of Health (NIH) and the Naval Sea Systems Command (NAVSEA). These contracts, predominantly set aside for small businesses, involve detailed patent-related work such as drafting and filing provisional and utility patent applications, preparing patent disclosures, reviewing patent applications, paying patent fees, and providing recommendations for divisional patent filings. The contract awards have ranged from $1,800 to $18,009, covering patent work in diverse technological areas including biotechnology, chemistry, mechanical engineering, and naval technologies. Most contracts have been firm fixed-price delivery orders or Blanket Purchase Agreement (BPA) calls, supporting research and development programs across civilian and defense sectors.
Mccoy Russell LLP holds two significant indefinite delivery/indefinite quantity (IDIQ) contracts: a $17 million NIH Patent Legal Services contract and a $7.5 million Naval Sea Systems Command Blanket Purchase Agreement. The NIH contract, awarded in April 2020, covers patent legal services across four technology categories and runs through April 2025, while the Naval contract, awarded in September 2022, provides patent services through September 2027. Both are multiple-award contracts that allow the firm to compete for and receive task orders supporting federal agencies' intellectual property needs. The NIH contract, in particular, has generated numerous delivery orders for patent application preparation, filing, and prosecution across various scientific and medical research domains, demonstrating the firm's specialized expertise in translating research innovations into protected intellectual property.
UPPAK1WRKTZ3 541110
Not listed 1410 NW Johnson St #201, Portland, OR 97209, USA
5/31/17 8/1/25